Effect of ferroportin polymorphism on iron homeostasis and infection

Clinica Chimica Acta

Volumn 416, Issue , 2013, Pages 20-25

  Kasvosve, Ishmael ^a  

^a UNIVERSITY OF BOTSWANA   (Botswana)

Author keywords

Ferroportin polymorphism; Infection; Iron homeostasis; SCL40A1 gene

Indexed keywords

FERROPORTIN; HEPCIDIN; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MEMBRANE PROTEIN;

AUTOSOMAL DOMINANT DISORDER; BACTERIAL VIRULENCE; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; GAIN OF FUNCTION MUTATION; GENE; GENE MUTATION; GENETIC POLYMORPHISM; HEMOCHROMATOSIS; HFE GENE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION SENSITIVITY; INFLAMMATION; INTERNALIZATION; INTESTINE CELL; IRON ABSORPTION; IRON BALANCE; IRON OVERLOAD; IRON TRANSPORT; LOSS OF FUNCTION MUTATION; LYSOSOME; MACROPHAGE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; RETICULOENDOTHELIAL SYSTEM; REVIEW; TRANSCRIPTION REGULATION;

ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; HOMEOSTASIS; HUMANS; POLYMORPHISM, GENETIC;

MAMMALIA;

EID: 84870978966     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.11.013     Document Type: Review

References (81)

1. Abboud S., Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000, 275:19906-19912.
2. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., et al. Positional cloning of zebrafish ferroportin identifies a conserved vertebrate iron exporter. Nature 2000, 403:776-781.
3. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000, 5:299-309.
4. Liu X.B., Yang F., Haile D.J. Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis 2005, 35:33-46.
5. Rice A.E., Mendez M.J., Hokanson C.A., Rees D.C., Björkman P.J. Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter. J Mol Biol 2009, 386:717-732.
6. Camaschella C., Roetto A., De Gobbi M. Genetic haemochromatosis: genes and mutations associated with iron loading. Best Pract Res Clin Haematol 2002, 15:261-276.
7. Mayr R., Janecke A.R., Schranz M., Griffiths W.J.H., Vogel W., Pietrangelo A., et al. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J Hepatol 2010, 53:941-949.
8. Donovan A., Lima C.A., Pinkus J.L., Pinkus G.S., Zon L.I., Robine S., et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 2005, 1:191-200.
9. Pinnix Z.K., Miller L.D., Wang W., D'Agostino R, Kute T., Willingham M.C., et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med 2010, 2(43):43ra56.
10. Wu L.J., Leenders A.G., Cooperman S., Meyron-Holtz E., Smith S., Land W., et al. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 2004, 1001:108-117.
11. Jeong S.Y., David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 2003, 278:27144-27148.
12. Khan Z.A., Farhangkhoee H., Barbin Y.P., Adams P.C., Chakrabarti S. Glucose-induced regulation of novel iron transporters in vascular endothelial cell dysfunction. Free Radic Res 2005, 39:1203-1210.
13. Nanami M., Ookawara T., Otaki Y., Ito K., Moriguchi R., Miyagawa K., et al. Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells. Arterioscler Thromb Vasc Biol 2005, 12:2495-2501.
14. Ward D.M., Kaplan J. Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta 2012, 1823:1426-1433.
15. Taylor M., Qu A., Anderson E.R., Matsubara T., Martin A., Gonzalez F.J., et al. Hypoxia-inducible factor 2alpha mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroentorology 2011, 140:2044-2055.
16. Knutson M.D., Vafa M.R., Haile D.J., Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 2003, 102:4191-4197.
17. Marro S., Chiabrando D., Messana E., Stolte J., Turco E., Tolosano E., et al. Heme controls ferroportin 1 (FPN1) transcription involving Bach 1, NrF2 and a MARE/ARE sequence at position -7007 of the FPN1 promoter. Haematologica 2010, 95:1261-1268.
18. Viatte L., Lesbordes-Brion J.C., Lou D.Q., Bennoun M., Nicolas G., Khan A., et al. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood 2005, 105:4861-4864.
19. Muckenthaler M.U., Galy B., Hentze M.W. Systemic iron homeostasis and the iron responsive element/iron regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr 2008, 28:197-213.
20. Liu X.B., Hill P., Haile D.J. Role of the ferroportin iron-responsive element in iron and nitric oxide dependent gene regulation. Blood Cells Mol Dis 2002, 29:315-326.
21. Lymboussaki A., Pignatti E., Montosi G., Garuti C., Haile D.J., Pietrangelo A. The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression. J Hepatol 2003, 39:710-715.
22. Zoller H., Koch R.O., Theurl I., Obrist P., Pietrangelo A., Montosi G., et al. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 2001, 120:1412-1419.
23. Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001, 276:7806-7810.
24. Liu X.B., Nguyen N.B.H., Marquess K.D., Yang F., Haile D.J. Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol Dis 2005, 35:47-56.
25. Pigeon C., Ilyin G., Courselaud B., Lerover P., Turlin B., Brissot P., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001, 276:7811-7819.
26. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006, 26:323-342.
27. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., Ganz T. Hepcidin, a putative mediator of inflammation, is a type II acute-phase protein. Blood 2003, 101:2461-2463.
28. Delaby C., Pilard N., Gonclaves A.S., Beaumont C., Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophage is enhanced by iron loading and down-regulated by hepcidin. Blood 2005, 106:3979-3984.
29. Shike H., Lauth X., Westerman M.E., Ostland V.E., Carlberg J.M., Van Olst J.C., et al. Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem 2002, 269:2232-2237.
30. Nicolas G., Chauvet C., Viattel L., Danan J.L., Bigard X., Devaux I., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia and inflammation. J Clin Invest 2002, 110:1037-1044.
31. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Ward D.M., Ganz T., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
32. De Domenico I., Ward D.M., Langelier C. The molecular mechanism of hepcidin-mediated internalization of ferroportin down-regulation. Mol Biol Cell 2007, 18:2569-2578.
33. De Domenico I., Lo E., Ward D.M., Kaplan J. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc Natl Acad Sci U S A 2009, 106:3800-3805.
34. Ross S.L., Tran L., Winters A., Lee K.J., Plewa C., Foltz I., et al. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosine or JAK-STAT. Cell Metab 2012, 15:905-917.
35. Qiao B., Sugianto P., Fung E., Del-Castillo-Rueda A., Moran-Jimenez M.J., Ganz T., et al. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab 2012, 15:918-924.
36. Galli A., Bergamaschi G., Recalde H., Biasiotto G., Santambrogio P., Boggi S., et al. Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages. Br J Haematol 2004, 127:598-603.
37. Chung B., Chaston T., Marks J., Surjit K.S., Sharp P.A. Hepcidin decreases iron transporter expression in vivo in mouse duodenum and spleen and in vitro THP-1 macrophages and intestinal Caco-2 cells. J Nutr 2009, 139:1457-1462.
38. De Domenico I., Zhang T.Y., Koening C.L., Branch R.W., London N., Lo E., et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 2010, 120:2395-2405.
39. Pietrangelo A., Montosi G., Totaro A., Garuti C., Conte D., Cassanelli S., et al. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med 1999, 341:725-732.
40. Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E., Cassanelli S., et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001, 108:619-623.
41. Devalia V., Carter K., Walker A.P., Perkins S.J., Worwood M., May A., et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin gene 1 (SLC11A3). Blood 2002, 100:695-697.
42. Wallace D.F., Pedersen P., Dixon J.L., Stephenson P., Searle J.W., Powell L.W., et al. Novel mutation in ferroportin 1 is associated with autosomal dominant hemochromatosis. Blood 2002, 100:692-694.
43. Roetto A., Merryweather-Clarke A.T., Daraio F., Livesey K., Pointon J.J., Barbabietola G., et al. A valine deletion of ferroportin 1: a common mutation in hemochromatosis type 4. Blood 2002, 100:733-734.
44. Cazzola M., Cremonesi L., Papaioannou M., Soriani N., Kioumi A., Charalambdou A., et al. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br J Haematol 2002, 119:539-546.
45. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 2004, 32:131-138.
46. Cazzola M. Role of ferritin and ferroportin genes in unexplained hyperferritinemia. Best Pract Res Clin Haematol 2005, 18:251-263.
47. De Domenico I., Ward D.M., Nemeth E., Vaughn M.B., Musci G., Ganz T., et al. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A 2005, 102:8955-8960.
48. Schimanski L.M., Drakesmith H., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 2005, 105:4096-4102.
49. Rivard S.R., Lanzara C., Grimand D., Carella M., Simard H., Ficarella R., et al. Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a large French-Canadian family. Haematologica 2003, 88:824-826.
50. Cremonesi L., Forni G.L., Soriani N., Lamagna M., Fermo I., Daraio F., et al. Genetic and clinical heterogeneity of ferroportin disease. Br J Haematol 2005, 131:663-670.
51. Beutler E., Barton J.C., Felitti V.J., Gelbart T., West C., Lee P.L., et al. Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis 2003, 31:305-309.
52. McNamara L., Gordeuk V.R., MacPhail A.P. Ferroportin (Q248H) mutations in African families with dietary iron overload. J Gastroenterol Hepatol 2005, 20:1855-1858.
53. Rivers C.A., Barton J.C., Gordeuk V.R., Acton R.T., Speechley M.R., Snively B.M., et al. Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol Dis 2007, 38:247-252.
54. Sham R.L., Phatak P.D., Nemeth E., Ganz T. Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood 2009, 114:493-494.
55. Girelli D., De Domenico I., Bozzini C., Campostrini N., Busti F., Castagna A., et al. Clinical, pathological, and molecular correlates in ferroportin disease. A study of two novel mutations. J Hepatol 2008, 49:664-671.
56. Koyama C., Wakusawa S., Hayashi H., Ueno T., Suzuki R., Yano M., et al. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation iron. Intern Med 2005, 44:990-993.
57. Jouanolle A.M., Douabin-Gicquel V., Halimi C., Loreal O., Fergelot P., Delacour T., et al. Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. J Hepatol 2003, 39:286-289.
58. Létocart E., Le Gac G., Majore S., Ka C., Radio F.C., Gourlaouen I., et al. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases. Br J Haematol 2009, 147:379-385.
59. Mayr R., Griffiths W.J., Hermann M., McFarlane I., Halsall D.J., Finkenstedt A., et al. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload. Gastroenterology 2011, 140:2056-2063.
60. Njajou O.T., de Jong G., Berghuis B., Vaessen N., Snijders P.J., Goossens J.P., et al. Dominant hemochromatosis due to N144H mutation of SLC11A3: clinical and biological characteristics. Blood Cells Mol Dis 2002, 29:439-443.
61. Arden K.E., Wallace D.F., Dixon J.L., Summerville L., Searle J.W., Anderson G.J., et al. A novel mutation in ferroportin 1 is associated with haemochromatosis in a Solomon Islands patient. Gut 2003, 52:1215-1217.
62. Hetet G., Devaux I., Soufir N., Grandchamp B., Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood 2003, 102:1904-1910.
63. Corradini E., Montosi G., Ferrara F., Caleffi A., Pignatti E., Borelli S., et al. Lack of enterocyte iron accumulation in the ferroportin disease. Blood Cells Mol Dis 2005, 35:315-318.
64. Drakesmith H., Schimanski L.M., Ormerod E., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 2005, 106:1092-1097.
65. Nekhai S., Xu M., Foster A., Kasvosve I., Diaz S., Machado R.F., et al. Reduced sensitivity of the ferroportin Q248H mutant to physiologic concentrations of hepcidin. Haematologica Oct 12 2012, (Epub ahead of print).
66. Sham R.L., Phatak P.D., West C., Lee P., Andrews C., Beutler E. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol Dis 2005, 34:157-161.
67. Gordeuk V.R., Caleffi A., Corradini E., Ferrara F., Jones R.A., Castro O., et al. Iron overload in Africans and African-Americans and a common mutation in the SCL 40A1 (ferroportin 1) gene. Blood Cells Mol Dis 2003, 31:299-304.
68. Kasvosve I., Gomo Z.A.R., Nathoo K.J., Matibe P., Mudenge B., Loyevsky M., et al. Effect of ferroportin Q248H polymorphism on iron status in African children. Am J Clin Nutr 2005, 82:1102-1106.
69. Albuquerque D., Manco L., Loua K.M., Arez A.P., Trovoada Mde J., Relvas L., et al. SLC40A1 Q248H allele frequencies and associated SLC40A1 haplotypes in three West African Population samples. Ann Hum Biol 2011, 38:378-381.
70. Masaisa F., Breman C., Gahutu J.B., Mukiibi J., Delanghe J., Philippe J. Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating serum hepcidin levels in Rwandese HIV positive women. Ann Hematol 2012, 91:911-916.
71. Schaible U.E., Kaufmann S.H. Iron and microbial infection. Nat Rev Microbiol 2004, 2:946-953.
72. Cartwright G.E., Lauritsen M.A., Jones P.J., Merill I.M., Wintrobe M.M. The anemia of infection I. Hypoferremia, hypercupremia, and alterations in porphyrin metabolism in patients. J Clin Invest 1946, 25:65-80.
73. Ganz T., Nemeth E. Iron sequestration and anemia of inflammation. Semin Hematol 2009, 46:387-393.
74. Knutson M.D., Oukka M., Koss L.M., Aydemir F., Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. PNAS 2005, 102:1324-1328.
75. Nairz M., Theurl I., Ludwiczek S., Theurl M., Mair S.M., Fritsche G., et al. The coordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol 2007, 9:2126-2140.
76. Paradkar P.N., De Domenico I., Durchfort N., Zohn I., Kaplan J., Ward D.M. Iron depletion limits intracellular bacterial growth in macrophages. Blood 2008, 112:866-874.
77. Johnson E.E., Sandgren A., Cherayil B.J., Murray M., Wessling-Resnick M. Role of ferroportin in macrophage-mediated immunity. Infect Immun 2010, 78:5099-5106.
78. Xu M., Kashanchi F., Foster A., Rotimi J., Turner W., Gordeuk V.R., et al. Hepcidin induces HIV-1 transcription by ferroportin. Retrovirology 2010, 7:104.
79. Chlosta S., Fishman D.S., Harrington L., Johnson E.E., Knutson M.D., Wessling-Resnick M., et al. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect Immun 2006, 74:3065-3067.
80. Baker M.A., Wilson D., Wallengren K., Sandgren A., Iartchouk O., Broodie N., et al. Polymorphisms in the gene that encodes the iron transport protein ferroportin 1 influence susceptibility to tuberculosis. J Infect Dis 2012, 205:1043-1047.
81. Kasvosve I., Debebe Z., Nekhai S., Gordeuk V.R. Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children. Clin Chim Acta 2010, 411:1248-1252.